MindWalk Holdings (HYFT) Gross Margin (2020 - 2026)
MindWalk Holdings (HYFT) reported Gross Margin of 0.0% for Q1 2026, down 6455.0% year-over-year from 0.0% in Q1 2025, and down 100.0% quarter-over-quarter from 64548.98% in Q4 2025.
MindWalk Holdings (HYFT) Gross Margin (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Gross Margin data on file, last reported at 0.0% in Q1 2026.
- Gross Margin for Q1 2026 came in at 0.0%, down 6455.0% year-over-year; the trailing twelve-month figure through Jan 2026 was 0.21% (down 5224.0% YoY), and the FY2025 annual result was 55.25%, up 609.0% from the prior year.
- Gross Margin eased to 0.0% in Q1 2026 per HYFT's latest filing, from 64548.98% in the prior quarter.
- Over five years, Gross Margin peaked at 73977154.72% in Q1 2022 and troughed at 0.0% in Q1 2026.
- A 5-year average of 4355438.6% and a median of 53.44% in 2022 frame the typical range for Gross Margin.
- The sharpest annual moves came in 2022 and 2023: Gross Margin soared 2000000000 bps in 2022, then tumbled 2000000000 bps in 2023.
- A 5-year view of Gross Margin shows it stood at 53.61% in 2022, then fell by 10 bps to 48.03% in 2023, then advanced by 6 bps to 51.1% in 2024, then surged by 126216 bps to 64548.98% in 2025, then slumped by 100 bps to 0.0% in 2026.
- Business Quant data shows HYFT's Gross Margin at 0.0% in Q1 2026, 64548.98% in Q4 2025, and 48.31% in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 79.04% |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 0.00% |
| Oct 31, 2025 | 64,548.98% |
| Jul 31, 2025 | 48.31% |
| Apr 30, 2025 | 63.89% |
| Jan 31, 2025 | 64.55% |
| Oct 31, 2024 | 51.10% |
| Jul 31, 2024 | 40.84% |
| Apr 30, 2024 | 48.12% |
| Jan 31, 2024 | 51.39% |
| Oct 31, 2023 | 48.03% |
| Jul 31, 2023 | 49.14% |
| Apr 30, 2023 | 59.44% |
| Jan 31, 2023 | 57.32% |
| Oct 31, 2022 | 53.61% |
| Jul 31, 2022 | 53.44% |
| Apr 30, 2022 | 63.29% |
| Jan 31, 2022 | 73,977,154.72% |
| Oct 31, 2021 | 58.65% |
| Jul 31, 2021 | 54.62% |
| Apr 30, 2021 | 56.94% |